| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785907 | Cancer Treatment Reviews | 2018 | 30 Pages |
Abstract
Despite a wide heterogeneity in the target population, different staging procedures and diverse treatment approaches among different trials, this systematic review confirms the role of ChT in combination with neoadjuvant long-course RT. Adjuvant ChT could be of value in selected patients with high-risk features, mainly if they do not respond to neoadjuvant RT. Further investigation is warranted on more intensified neoadjuvant regimens including ChT for MRI-defined high-risk patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Susana Roselló, Federica Papaccio, Desamparados Roda, Noelia Tarazona, Andrés Cervantes,